គេហទំព័រព័ត៌មានកម្ពុជា

Meiji and Fujitsu launch world’s first rRAFU(TM) pilot to assess future malnutrition and frailty risk

Tokyo and Kawasaki, Japan, Feb 12, 2026 – (JCN Newswire via SeaPRwire.com) – Meiji Co., Ltd. and Fujitsu Limited today announced the start of a pilot project towards the social implementation of rRAFU™ [1] (Rapid Risk Assessment Tool for Future Undernutrition Status), the world’s first [2] indicator to predict future risks of malnutrition and frailty (developed by Meiji.) The pilot will focus on residents aged 60 and over in Kawasaki City, Kanagawa Prefecture.This pilot project incorporates a self-care support app, built by Meiji and Fujitsu, that combines rRAFU with Fujitsu’s AI-driven behavioral change support service. The project will verify the effectiveness of rRAFU and the app’s ability to promote behavioral change in frailty prevention among participants in the pilot.Both companies aim to contribute to frailty prevention among the elderly by enabling early identification of malnutrition and frailty risks, which are often difficult to self-diagnose. Through the self-care support app utilizing rRAF…

Fujitsu Group starts manufacturing sovereign AI servers in Japan to enhance digital sovereignty

KAWASAKI, Japan, Feb 12, 2026 – (JCN Newswire via SeaPRwire.com) – Fujitsu today announced that it will start manufacturing “Made in Japan” sovereign AI servers designed to support mission-critical operations. Production is slated to begin in March 2026 at the Fujitsu Group’s Kasashima Plant in Japan. Fujitsu will also start production of Made in Japan servers equipped with Fujitsu’s high-performance, energy-efficient FUJITSU-MONAKA (1) processor within fiscal year 2026 (ending March 31st 2027). Geopolitical shifts, rising cyber threats, and regulatory demands have made critical information protection an urgent global imperative. In Japan, as the designation of specified essential infrastructure service providers progresses under the Economic Security Promotion Act, system risk management and digital sovereignty are paramount for customers that are dealing with critical infrastructure. This includes minimizing data leakage, ensuring autonomous operation, complying with local laws, mainta…

Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran

BOSTON, Feb 11, 2026 – (ACN Newswire via SeaPRwire.com) – Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects with laboratory-confirmed acute viral infection. The Bioxyytran Trial reports complete elimination of viral load  in 100% of patients at day 7 versus placebo (p=.001).The completed Phase 2 clinical study was a randomized, double-blind, placebo-controlled, dose-optimization trial evaluating orally administered ProLectin-M in subjects with acute viral infection. The study enrolled 38 subjects, all of whom completed the study. Subjects were randomized to receive one of three ProLectin-M dose levels or a matching placebo, administered over a seven-day treatment period.Viral shedding was assessed using RT-PCR analysis of nasopharyngeal swabs collected at predefined timepoints, with viral clearance defined as non-detection of viral RNA below es…

Premiere of Three-Row Highlander BEV in North America

Toyota City, Japan, Feb 11, 2026 – (JCN Newswire via SeaPRwire.com) – Toyota Motor Corporation (Toyota) announced that it will expand its battery electric vehicle (BEV) lineup in North America as part of its multi-pathway approach toward achieving a carbon-neutral society. As part of this effort, Toyota Motor North America (TMNA), Toyota’s North American business entity, premiered a new BEV model of the three-row SUV Highlander on February 11 (JST; February 10 PST) in Ojai, California. Sales in North America are expected to begin in late 2026.Highlander BEV (North American model)Toyota is committed to product- and region-centered management with the aim of making ever-better cars. In developing powertrain systems to achieve carbon neutrality, Toyota is rolling out a variety of mobility solutions under its multi-pathway approach, offering electrified vehicle options tailored to meet customer needs in each country and region around the world.To steadily advance its multi-pathway approach in the North American m…

Honda Works Partner Aston Martin Aramco Formula One(TM) Team Unveils Livery of “AMR26” F1(TM) Machine Equipped with Honda Power Unit Ahead of the 2026 Race Season

TOKYO, Feb 10, 2026 – (JCN Newswire via SeaPRwire.com) – Ahead of the start of the 2026 FIA*1 Formula One World Championship (F1TM) season, Honda works partner Aston Martin Aramco Formula One™ Team (AMAF1), has unveiled the livery for its new F1 machine, the AMR26. Powered by the Honda F1 power unit, the RA626H, the AMR26 will take on the challenge of F1, the pinnacle of automobile racing.The AMR26 is the first F1 machine designed for the team by Adrian Newey, AMAF1 Managing Technical Partner and Team Principal, and it is being developed at the AMR Technology Campus, at AMAF1 headquarters in Silverstone, the U.K.Together with AMAF1, Honda will conduct pre-season testing in Bahrain for a total of six days, — February 11-13 and 18-20 — and make necessary adjustments before taking on the season-opening race at the Australian Grand Prix on Sunday, March 8, 2026.*1 Fédération Internationale de lʼAutomobileComments by Adrian Newey, Managing Technical Partner and Team Principal,&…

Honda to Make Organizational Changes to Further Enhance Competitiveness its Motorcycle, Automobile and Power Products Business

TOKYO, Japan, Feb 10, 2026 – (JCN Newswire via SeaPRwire.com) – Honda Motor Co., Ltd. (Honda) today announced that the company will make organizational and operational changes, effective April 1, 2026, in order to sustainably offer the joy and freedom of mobility all around the world through its mobility products and services.In 2020, with the aim of solidifying its existing business while preparing for future growth, Honda separated two key research and development functions — the development of production models and research on future technologies — enabling each group to focus on its roles. This initiative generated solid results including contribution to Honda business and the enhancement of technological competitiveness.With the global business environment surrounding Honda changing faster than expected, the company will further strengthen its ability to grasp market and technology trends more accurately and deliver the original technologies and new value of Honda to the market at the optimal…

KS Energy and Hitachi Collaborate on Extra-High Voltage Battery Energy Storage System

TOKYO, Feb 10, 2026 – (JCN Newswire via SeaPRwire.com) – KS Energy Co., Ltd. (“KS Energy”), a renewable energy business company and Hitachi, Ltd. (TSE:6501, “Hitachi”) agreed on February 6 to collaborate on the development and operation of an Extra-High Voltage Grid Battery Energy Storage System*1 within Kumamoto Prefecture, as well as the development and operation of power trading businesses. Hitachi will provide project development support for KS Energy’s development of the project and jointly promote the development and operation of this battery energy storage system (tentative name)*2 . Additionally, KS Energy will also explore the introduction of a power trading support system planned for development by Hitachi.This initiative will support stable power supply in the Kyushu region and contribute to achieving carbon neutrality.*1 Extra-High Voltage Grid Battery Energy Storage System: Large-scale battery storage facilities directly connected to the power grid (such as transmission lines) with a …

Biologics License Application for Subcutaneous Formulation of “LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

TOKYO and CAMBRIDGE, Mass., Feb 10, 2026 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of “LEQEMBI®” (brand name in China: “乐意保®”, generic name: lecanemab), an anti-amyloid beta (Aβ) protofibril antibody, which was accepted in January 2026, has been designated for Priority Review by the National Medical Products Administration (NMPA) of China.The Priority Review and Approval Procedure was implemented by the NMPA with the aim of accelerating research, development and launch of new medicines that have significant clinical value. Under this Procedure, the assessment period is expected to be shortened.If approved, the SC-AI of 500…

NEC Exhibits at MWC Barcelona 2026, the World’s Largest Mobile-Related Exhibition

TOKYO, Feb 9, 2026 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) will exhibit at MWC Barcelona 2026, the world’s largest mobile-related exhibition, held from Monday, March 2 to Thursday, March 5, 2026, in Barcelona, Spain.NEC booth renderingUnder the theme of “Building an AI-Native Society,” NEC will showcase its initiatives for the social implementation of hardware and software to realize advanced communications in an AI-Native society in the Beyond 5G/6G era.On March 2, the first day of the exhibition, Dr. Juergen Quittek, Head of NEC Laboratories Europe, will participate as a panelist in a session titled “AI and Us: What Are We Really Building Toward?” He will discuss the expanding applications of AI, drawing on NEC’s efforts in this field.Furthermore, the NEC exhibition booth will showcase the latest vRAN-compatible Radio Units (RUs) for enhancing the efficiency of 5G networks, low-power RU amplifier modules, AI automation for realizing network automation through software…

CITIC Telecom CPC Wins Two Awards, Celebrating ‘Innovation Never Stops’ for 25 Years, recognizing Cybersecurity & Innovation Excellence

HONG KONG, Feb 9, 2026 – (ACN Newswire via SeaPRwire.com) – CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883) is pleased to announce a triumph in winning two prestigious awards as 2026 unfolds, recognizing its cybersecurity and continuous innovation capabilities. CITIC Telecom CPC’s AI-driven Security Operations Centre (AI SOC) is honored “Best AI SOC Service Provider” in “IT PRO Corporate Choice Award 2025” from the well-known IT media . In addition, two security experts of CITIC Telecom CPC have won two accolades in “Internet and Cloud Services” sector of “Cyber Security Professional Awards 2025” organized by the Hong Kong Police Force (Cyber Security and Technology Crime Bureau, CSTCB).Mr. Brook Wong, Chief Executive Officer of CITIC Telecom CPC, said, “2026 marks the 25th anniversary of CITIC Telecom CPC. Our tagline “Innova…

JCB Announces Collaboration with Resorts World Sentosa in Singapore

TOKYO//SINGAPORE, Feb 9, 2026 – (JCN Newswire via SeaPRwire.com) – JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan’s only international payment brand, today announced a new collaboration with RESORTS WORLD AT SENTOSA PTE. LTD. (RWS), targeted at Japanese tourists. The partnership with RWS is designed to enhance the travel experience for Japanese visitors to Singapore.Located on Sentosa, Singapore’s premier resort island, Resorts World Sentosa is one of the nation’s leading integrated lifestyle destinations, welcoming millions of local and international visitors annually across its attractions, dining, entertainment and lifestyle offerings. This collaboration aims to curate meaningful experiences that enhance every stage of the visitor journey for Japanese guests.JCB and RWS today launched exclusive privileges for Japan-issued JCB cardmembers visiting Singapore’s leading integrated resort. Under this collaboration, eligible JCB cardmembers boo…

Anime Tokyo Station: “That Time I Got Reincarnated as a Slime” Special Exhibition, February 21 to May 24, 2026

TOKYO, Feb 9, 2026 – (JCN Newswire via SeaPRwire.com) – Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devout fan base around the world. The facility attracts visitors of all ages and has welcomed 253,236 guests from Japan and overseas (as of January 18, 2026).©Taiki Kawakami, Fuse, KODANSHA/ “Ten-Sura”Anime Tokyo Station regularly hosts special exhibitions for popular anime. From February 21 (Sat.) to May 24 (Sun.), 2026, it will hold the “That Time I Got Reincarnated as a Slime” Special Exhibition.This popular TV anime first aired in 2018 and has now reached its third season. The story follows Satoru Mikami, an office worker who is suddenly reincarnated as a slime in another world after being caught up in an incident. Taking on the name Rimuru Tempest, he embarks on a series of adventures in this new realm. At present, in addition to the fourth season of the TV anime that is slated to air, a second theatrical re…

Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market

All-new Versa VanTOKYO, Feb 6, 2026 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Mitsubishi Motors Philippines Corporation (MMPC), a subsidiary of Mitsubishi Motors in the Philippines, began sales of the all-new Versa Van on February 6. The model is an OEM-supplied commercial vehicle by Nissan Motor Co., Ltd. (hereafter, Nissan).The all-new Versa Van offers five-row seating for up to 15 passengers and features a spacious interior optimized for transporting people, supporting a wide range of commercial applications, including shuttle services. Powered by a 2.5-liter inline four-cylinder diesel engine, the model delivers strong torque from the moment of acceleration, ensuring confident performance even when carrying many passengers or driving on steep inclines. With this new model, Mitsubishi Motors aims to strengthen its commercial vehicle lineup in the Philippines and meet customer needs alongside the existing L300 model.As Alliance partners,…

Establishment of the World’s First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony’s High-Performance Products

TOKYO, Feb 6, 2026 – (JCN Newswire via SeaPRwire.com) – Sony Corporation (Sony), Mitsubishi Corporation, ADEKA CORPORATION , CHIMEI Corporation, ENEOS Corporation, Formosa Chemicals & Fibre Corporation, Hanwha Impact Corporation, Idemitsu Kosan Co., Ltd., Mitsui Chemicals, Inc., Neste Corporation, Qingdao Haier New Material Development Co., Ltd., SK Geo Centric Co., Ltd., Toray Industries, Inc., and Toray Advanced Materials Korea Inc. have jointly established the world’s first global supply chain consisting of fourteen companies across five countries and regions for the production of renewable plastics*2 that can be used in Sony’s high-performance audio-visual products. The various plastic materials manufactured through this supply chain are slated for use in Sony’s products that will be launched worldwide.<Overview of the Entire Supply Chain>(1) Production of renewable naphtha — Neste Corporation / (2) Production of renewable styrene monomer — Idemitsu Kosan Co…

Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan

TOKYO and SHANGHAI, Feb 6, 2026 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO: Jason Zhu, “Henlius”) announced today the conclusion of an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab (generic name, marketed as HANSIZHUANG in China and Hetronifly® in the EU) in Japan.Serplulimab, a novel anti-PD-1 monoclonal antibody developed by Henlius, is reported to possess a unique binding mode that differs from existing anti-PD-1 antibodies. 1 In China, it has been approved for indications such as squamous non-small cell lung cancer (sqNSCLC), extensive-stage small cell lung cancer (ES-SCLC), non-squamous non-small cell lung cancer (nsNSCLC), and esophageal squamous cell carcinoma (ESCC). In the EU, it has been approved for ES-SCLC. It is the world’s first anti-PD-1 antibody to …

Fujitsu Japan and JMDC announce collaboration to build sustainable healthcare system in Japan through enhanced medical data utilization

Kawasaki and Tokyo, Japan, Feb 6, 2026 – (JCN Newswire via SeaPRwire.com) – Fujitsu Japan Limited and JMDC Inc. today announced the commencement of a collaboration aimed at advancing medical care and contributing to the establishment of a sustainable healthcare system in Japan.This collaboration, which began on January 5, leverages JMDC’s expertise in utilizing anonymized medical data and Fujitsu Japan’s customer base. Fujitsu Japan holds the top share in the Japanese electronic health record (EHR) market for medical institutions. This synergy will accelerate the utilization of medical data by medical institutions and organizations that are part of the healthcare system, while also supporting data-driven management decision-making.This collaboration will see the two companies combine Fujitsu Japan’s knowledge in the medical field and advanced technologies including AI, with JMDC’s prediction models based on insurance user data and its expertise cultivated through Pep Up, one of Japan’s largest personal health…

Genesys and Fujitsu Transform AEON Financial Service’s Contact Center Operations with Genesys Cloud Delivers Customers an Improved Self-Service Experience Resulting in Higher Completion and Reduced Wait Times

Tokyo and Kawasaki, Japan, Feb 6, 2026 – (JCN Newswire via SeaPRwire.com) – Genesys® Cloud Services, Inc. (Headquarters: Minato-ku, Tokyo; President: Paul Ito Ricci, hereinafter Genesys), a global cloud leader in AI-Powered Experience Orchestration, and Fujitsu Limited (Headquarters: Kawasaki City, Kanagawa Prefecture; President and CEO: Takahito Tokita; hereinafter Fujitsu) which led the implementation of Genesys Cloud, announced the successful transformation of AEON Financial Service Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; President and CEO: Tomoharu Fukayama; hereinafter AEON Financial Service) contact center operations and the completion of its effectiveness evaluation.As part of this contact center transformation initiative, AEON Financial Service deployed Genesys Cloud™, a unified experience orchestration platform. Because of the composability of the Genesys Cloud platform, Fujitsu implemented customizations to meet its unique business requirements, including reporting management and syste…

TANAKA PRECIOUS METAL TECHNOLOGIES establishes total solutions system for contract manufacturing of various test kits including in vitro diagnostics

TOKYO, Feb 5, 2026 – (JCN Newswire via SeaPRwire.com) – TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. (Head Office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), a company engaged in the industrial precious metals business of TANAKA, announced today that it has established a total solution system capable of supporting all processes in the contract manufacturing business for various test kits including in vitro diagnostics.Until now, TANAKA has been responsible primarily for processes from developing and manufacturing test kits to bulk production of extraction buffer. At this time, TANAKA established dedicated production lines for the dispensing and packaging of extraction buffer, creating a system that enables it to complete all processes in-house from development to manufacture of final products. This enables TANAKA to reduce costs and the time for external outsourcing and transportation, making it possible to deliver high-quality products in shorter times.In addition, TANAKA will …

Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013

Shanghai, January 5, 2026 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an exclusive license agreement with Shaanxi Micot Pharmaceutical Technology Co., Ltd. (“Micot”) to commercialize MT1013, the world’s first-in-class dual-targeting receptor agonist polypeptide that simultaneously targets the Calcium-Sensing Receptor (CaSR) and the Osteogenic Growth Peptide (OGP) receptor and is primarily developed with Secondary Hyperparathyroidism (SHPT) as its leading indication, in China and Asia-Pacific (excluding Japan).According to the agreement, Everest Medicines will pay Micot an upfront payment of RMB 200 million and potential regulatory and commercial milestone payments of up to RMB 1,040 million. MT1013 has entered Phase III clinical trial in China and the …

Hitachi significantly expands exhibits at the “Hitachi Building Solutions Lab”, a research facility for collaborative creation with customers

– A branding area showcasing Hitachi’s journey from its founding to the vision it aims to achieve through Inspire 2027.(Top left)- A three-sided immersive theater presenting the future of buildings through powerful, engaging visual experiences.(Top right)- The entrance to the exhibition area where visitors can experience Hitachi’s comprehensive capabilities broughttogether under the One Hitachi. (Bottom left)- An interactive corner that visualizes and demonstrates commercial air conditioning control using augmented realitytechnology. (Bottom right)TOKYO, Feb 5, 2026 – (JCN Newswire via SeaPRwire.com) – Hitachi, Ltd. (TSE: 6501, “Hitachi”) and Hitachi Building Systems Co., Ltd. (“Hitachi Building Systems”, part of Hitachi’s Connective Industries Sector (“CI Sector”)) will significantly expand the exhibits at “Hitachi Building Solutions Lab”, a customer co-creation research facility. The facility, located in Tokyo, will reopen in its new form on …